The Abnormal Phenotypes of Cartilage and Bone in Calcium-Sensing Receptor Deficient Mice Are Dependent on the Actions of Calcium, Phosphorus, and PTH

English version České info

Patients with neonatal severe hyperparathyroidism (NSHPT) are homozygous for the calcium-sensing receptor (CaR) mutation and have very high circulating PTH, abundant parathyroid hyperplasia, and severe life-threatening hypercalcemia. Mice with homozygous deletion of CaR mimic the syndrome of NSHPT. To determine effects of CaR deficiency on skeletal development and interactions between CaR and 1,25(OH)₂D₃ or PTH on calcium and skeletal homeostasis, we compared the skeletal phenotypes of homozygous CaR–deficient (CaR^−/−) mice to those of double homozygous CaR– and 1α(OH)ase–deficient [CaR^−/−1α(OH)ase^−/−] mice or those of double homozygous CaR– and PTH–deficient [CaR^−/−PTH^−/−] mice at 2 weeks of age. Compared to wild-type littermates, CaR^−/− mice had hypercalcemia, hypophosphatemia, hyperparathyroidism, and severe skeletal growth retardation. Chondrocyte proliferation and PTHrP expression in growth plates were reduced significantly, whereas trabecular volume, osteoblast number, osteocalcin-positive areas, expression of the ALP, type I collagen, osteocalcin genes, and serum ALP levels were increased significantly. Deletion of 1α(OH)ase in CaR^−/− mice resulted in a longer lifespan, normocalcemia, lower serum phosphorus, greater elevation in PTH, slight improvement in skeletal growth with increased chondrocyte proliferation and PTHrP expression, and further increases in indices of osteoblastic bone formation. Deletion of PTH in CaR^−/− mice resulted in rescue of early lethality, normocalcemia, increased serum phosphorus, undetectable serum PTH, normalization in skeletal growth with normal chondrocyte proliferation and enhanced PTHrP expression, and dramatic decreases in indices of osteoblastic bone formation. Our results indicate that reductions in hypercalcemia play a critical role in preventing the early lethality of CaR^−/− mice and that defects in endochondral bone formation in CaR^−/− mice result from effects of the marked elevation in serum calcium concentration and the decreases in serum phosphorus concentration and skeletal PTHrP levels, whereas the increased osteoblastic bone formation results from direct effects of PTH.

Vyšlo v časopise: The Abnormal Phenotypes of Cartilage and Bone in Calcium-Sensing Receptor Deficient Mice Are Dependent on the Actions of Calcium, Phosphorus, and PTH. PLoS Genet 7(9): e32767. doi:10.1371/journal.pgen.1002294
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002294

Souhrn

Zdroje

1. HauacheOM 2001 Extracellular calcium-sensing receptor: structural and functional features and association with diseases. Braz J Med Biol Res 34 577 584

2. LawWMJrHeathH3rd 1985 Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenetic studies in 21 families. Ann Intern Med 102 511 519

3. MarxSJAttieMFLevineMASpiegelAMDownsRWJr 1981 The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) 60 397 412

4. PollakMRChouYHMarxSJSteinmannBColeDE 1994 Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest 93 1108 1112

5. HoCConnerDAPollakMRLaddDJKiforO 1995 A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 11 389 394

6. GarnerSCPiMTuQQuarlesLD 2001 Rickets in cation-sensing receptor-deficient mice: an unexpected skeletal phenotype. Endocrinology 142 3996 4005

7. ChangWTuCChenTHBikleDShobackD 2008 The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development. Sci Signal 1 ra1

8. MiaoDHeBKaraplisACGoltzmanD 2002 Parathyroid hormone is essential for normal fetal bone formation. J Clin Invest 109 1173 1182

9. MiaoDHeBLanskeBBaiXYTongXK 2004 Skeletal abnormalities in Pth-null mice are influenced by dietary calcium. Endocrinology 145 2046 2053

10. KosCHKaraplisACPengJBHedigerMAGoltzmanD 2003 The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone. J Clin Invest 111 1021 1028

11. TuQPiMKarsentyGSimpsonLLiuS 2003 Rescue of the skeletal phenotype in CasR-deficient mice by transfer onto the Gcm2 null background. J Clin Invest 111 1029 1037

12. BrenzaHLKimmel-JehanCJehanFShinkiTWakinoS 1998 Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter. Proc Natl Acad Sci U S A 95 1387 1391

13. MurayamaATakeyamaKKitanakaSKoderaYHosoyaT 1998 The promoter of the human 25-hydroxyvitamin D3 1 alpha-hydroxylase gene confers positive and negative responsiveness to PTH, calcitonin, and 1 alpha, 25(OH)2D3. Biochem Biophys Res Commun 249 11 16

14. CantleyLKRussellJLettieriDSherwoodLM 1985 1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture. Endocrinology 117 2114 2119

15. ChanYLMcKayCDyeESlatopolskyE 1986 The effect of 1,25 dihydroxycholecalciferol on parathyroid hormone secretion by monolayer cultures of bovine parathyroid cells. Calcif Tissue Int 38 27 32

16. SzaboAMerkeJBeierEMallGRitzE 1989 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int 35 1049 1056

17. LiuSMKoszewskiNLupezMMallucheHHOliveraA 1996 Characterization of a response element in the 5′-flanking region of the avian (chicken) PTH gene that mediates negative regulation of gene transcription by 1,25-dihydroxyvitamin D3 and binds the vitamin D3 receptor. Mol Endocrinol 10 206 215

18. BeckermanPSilverJ 1999 Vitamin D and the parathyroid. Am J Med Sci 317 363 369

19. PandaDKMiaoDTremblayMLSiroisJFarookhiR 2001 Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci U S A 98 7498 7503

20. DardenneOPrud'hommeJArabianAGlorieuxFHSt-ArnaudR 2001 Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 142 3135 3141

21. FraserDKoohSWKindHPHolickMFTanakaY 1973 Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. N Engl J Med 289 817 822

22. XueYKaraplisACHendyGNGoltzmanDMiaoD 2005 Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development. Hum Mol Genet 14 1515 1528

23. FukugawaMKurokawaK 2002 Calcium homeostasis and imbalance. Nephron 92 Suppl 1 41 45

24. KremerRBolivarIGoltzmanDHendyGN 1989 Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 125 935 941

25. PandaDKMiaoDBolivarILiJHuoR 2004 Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 279 16754 16766

26. NajaRPDardenneOArabianASt ArnaudR 2009 Chondrocyte-specific modulation of Cyp27b1 expression supports a role for local synthesis of 1,25-dihydroxyvitamin D3 in growth plate development. Endocrinology 150 4024 4032

27. ChangWTuCPrattSChenTHShobackD 2002 Extracellular Ca(2+)-sensing receptors modulate matrix production and mineralization in chondrogenic RCJ3.1C5.18 cells. Endocrinology 143 1467 1474

28. ChangWTuCChenTHKomuvesLOdaY 1999 Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology 140 5883 5893

29. RodriguezLChengZChenTHTuCChangW 2005 Extracellular calcium and parathyroid hormone-related peptide signaling modulate the pace of growth plate chondrocyte differentiation. Endocrinology 146 4597 4608

30. RodriguezLTuCChengZChenTHBikleD 2005 Expression and functional assessment of an alternatively spliced extracellular Ca2+-sensing receptor in growth plate chondrocytes. Endocrinology 146 5294 5303

31. AmizukaNKaraplisACHendersonJEWarshawskyHLipmanML 1996 Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development. Dev Biol 175 166 176 Write to the Help Desk NCBI | NLM | NIH Department of Health & Human Services Privacy Statement | Freedom of Information Act | Disclaimer

32. KaraplisACLuzAGlowackiJBronsonRTTybulewiczVL 1994 Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8 277 289

33. MiaoDLiJXueYSuHKaraplisAC 2004 Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice. Endocrinology 145 3554 3562

34. KremerRSebagMChampignyCMeerovitchKHendyGN 1996 Identification and characterization of 1,25-dihydroxyvitamin D3-responsive repressor sequences in the rat parathyroid hormone-related peptide gene. J Biol Chem 271 16310 16316

35. Tovar SepulvedaVAFalzonM 2002 Regulation of PTH-related protein gene expression by vitamin D in PC-3 prostate cancer cells. Mol Cell Endocrinol 190 115 124

36. ShuLJiJZhuQCaoGKaraplisA 2011 The calcium-sensing receptor mediates bone turnover induced by dietary calcium and parathyroid hormone in neonates. J Bone Miner Res 26 1057 1071

37. DvorakMMSiddiquaAWardDTCarterDHDallasSL 2004 Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci U S A 101 5140 5145

38. YamaguchiTChattopadhyayNKiforOBrownEM 1998 Extracellular calcium (Ca2+(o))-sensing receptor in a murine bone marrow-derived stromal cell line (ST2): potential mediator of the actions of Ca2+(o) on the function of ST2 cells. Endocrinology 139 3561 3568

39. MalgaroliAMeldolesiJZalloneAZTetiA 1989 Control of cytosolic free calcium in rat and chicken osteoclasts. The role of extracellular calcium and calcitonin. J Biol Chem 264 14342 14347

40. MoongaBSMossDWPatchellAZaidiM 1990 Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption. J Physiol 429 29 45

41. ZaidiMKerbyJHuangCLAlamTRathodH 1991 Divalent cations mimic the inhibitory effect of extracellular ionised calcium on bone resorption by isolated rat osteoclasts: further evidence for a “calcium receptor”. J Cell Physiol 149 422 427

42. KanataniMSugimotoTKanzawaMYanoSChiharaK 1999 High extracellular calcium inhibits osteoclast-like cell formation by directly acting on the calcium-sensing receptor existing in osteoclast precursor cells. Biochem Biophys Res Commun 261 144 148

43. KamedaTManoHYamadaYTakaiHAmizukaN 1998 Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells. Biochem Biophys Res Commun 245 419 422

44. MentaverriRYanoSChattopadhyayNPetitLKiforO 2006 The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis. FASEB J 20 2562 2564

45. WallerSKurzawinskiTSpitzLThakkerRCranstonT 2004 Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy. Eur J Pediatr 163 589 594

46. Al-ShanafeySAl-HosainiRAl-AshwalAAl-RabeeahA 2010 Surgical management of severe neonatal hyperparathyroidism: one center's experience. J Pediatr Surg 45 714 717

47. MiaoDBaiXPandaDMcKeeMKaraplisA 2001 Osteomalacia in hyp mice is associated with abnormal phex expression and with altered bone matrix protein expression and deposition. Endocrinology 142 926 939

48. ParfittAMDreznerMKGlorieuxFHKanisJAMallucheH 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2 595 610

49. MiaoDHeBJiangYKobayashiTSoroceanuMA 2005 Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest 115 2402 2411